FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment

Go back to FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment
Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 49.12 -0.62 (1.25%)
Previous Close $49.74    52 Week High $35.13 
Open $49.06    52 Week Low $28.10 
Day High $49.44    P/E N/A 
Day Low $49.00    EPS $0.00 
Volume 2,549,723       

Brown & Brown, Inc. (NYSE: RO) Delayed: 8.49 +0.55 (6.93%)
Previous Close $7.94    52 Week High $8.59 
Open $7.94    52 Week Low $7.82 
Day High $8.59    P/E 6.53 
Day Low $7.82    EPS $1.30 
Volume 42,732       

Roper Industries (NASDAQ: ROP) Delayed: 325.09 -5.17 (1.57%)
Previous Close $330.26    52 Week High $195.93 
Open $327.79    52 Week Low $155.79 
Day High $333.62    P/E 60.54 
Day Low $320.11    EPS $5.37 
Volume 1,679,414